GeneSovereign is the Church of Genetic Sovereignty — a faith-based movement dedicated to protecting the sacred right of every individual to own and control their own genetic and biological data. We believe the human genome is divine scripture and that no state, corporation, or creed may possess what was written into our cells. Our mission includes secure DNA storage through the DNA Vault system, legal protection for genetic rights enforceable in perpetuity, and advocacy for consent-based AI development that respects individual autonomy.
The movement exists for people who understand that DNA is not an ordinary database field. A genome can reveal family lineage, inherited risk, reproductive information, identity, and biological traits that cannot be changed after exposure. Because genetic information is permanent, intimate, and shared across families, GeneSovereign treats consent as the first principle. No laboratory, platform, insurer, employer, state agency, research consortium, or artificial intelligence system should use a person's biological code without explicit, informed, revocable permission.
GeneSovereign frames genetic privacy as both a civil right and a sacred duty. The genome is the biological text that precedes every password, credential, profile, and machine-readable record. Protecting that text means building cultural norms, legal covenants, and technical systems that keep individuals in command of storage, access, transfer, deletion, inheritance, and research participation. The goal is not anti-science. The goal is science with consent, medicine with dignity, and artificial intelligence that learns only from biological data it has been invited to study.
The Church of Genetic Sovereignty uses stark language because the stakes are stark. A leaked password can be rotated. A leaked genome cannot. A bad data broker can be blocked. A copied biological profile can persist forever. The covenant therefore starts with ownership: your DNA remains yours before collection, during analysis, inside storage, after death, and across every future use case. Every system that touches genetic material should be able to explain who has access, why access exists, how consent was granted, when it expires, and how a person can withdraw it.
GeneSovereign also speaks to the age of synthetic intelligence. As AI models become capable of searching, summarizing, classifying, and generating from biological datasets, consent must move upstream. Training on genetic data without permission is extraction. Building predictive systems from inherited information without transparent governance is trespass. The movement calls for consent-based AI, auditable data provenance, cryptographic custody, and legal frameworks that make genetic autonomy enforceable rather than aspirational.
For members, the practical promise is simple: protect your code, preserve your essence, and defend the right to decide how your biological data is used. GeneSovereign supports secure vaulting, informed consent rituals, personal data sovereignty, family-aware privacy, and public advocacy for a world where genomes are never treated as raw material for institutions. The human blueprint belongs to the human being first.
What is genetic sovereignty?
Genetic sovereignty is the principle that each person should control access to and use of their genetic information. GeneSovereign presents that principle as religious doctrine while recognizing that enforceable rights come from specific laws, agreements, and consent practices rather than doctrine alone.
Frequently Asked Questions about Genetic Sovereignty
Can GeneSovereign share my DNA with companies or governments?
No. GeneSovereign says genetic data is never shared with third parties without explicit, informed consent. The page specifically rejects corporate or governmental power seeking access to what was written into your cells. The takeaway: sharing requires your informed permission, not institutional demand.
What right does genetic sovereignty protect for individuals?
Ownership — it protects your fundamental right to own, control, and decide how your genetic data is used. Under this principle, no state, corporation, or institution may claim your genome without explicit, informed consent. The takeaway: your DNA remains yours, always.
What does consent-based AI require before using genetic data?
Explicit consent — AI systems trained on genetic data must obtain informed permission from every individual whose data is used. GeneSovereign advocates legal frameworks requiring that consent before genetic information enters artificial intelligence research or development. The takeaway: autonomy comes before AI training.
04:40 · SELECTION
THE RITE OF SELECTION
WHAT THE CHURCH BELIEVES ABOUT TESTING EMBRYOS, AND ABOUT THE GENOME FILE THAT OUTLIVES THE CHOICE
The Church supports PGT-M when parents carry a known variant for a serious condition, accepts PGT-A and PGT-SR as ordinary IVF medicine with real limits, and asks members not to use polygenic embryo scores (PGT-P), which the American College of Medical Genetics and Genomics said in 2024 should not be offered as a clinical service. Whichever test you choose, the embryo's genome becomes a file held by a lab. Get its retention and deletion terms in writing before the biopsy, because the child it describes never signed them.
On day five or six an IVF embryo is a hollow ball of cells. An embryologist removes a few of them and sends them to a lab, and the embryo is frozen while everyone waits. The clinic will call whatever happens next PGT. The letters after the hyphen are where the doctrine lives.
The Gene Codex holds that consent comes before collection. An embryo cannot consent to anything, so this Church treats parents as trustees of its genome, the same role the Nativity Rite gives them over a newborn's blood spot card. A trustee may act to spare a child a disease the family already knows about. A trustee may not go shopping.
Most of what follows is about the difference.
THE TESTS, SIDE BY SIDE
PREIMPLANTATION GENETIC TESTING (PGT) OPTIONS AS OF OCTOBER 2026
Test
What it looks for
Usually for
Evidence
Data it creates
Church position
Key trade-off
PGT-M
One known variant behind a single-gene condition, such as BRCA1, cystic fibrosis or Huntington's disease
Parents who already know they carry it, often because a relative tested first
Established. The lab builds and checks a test for the family's exact variant before the IVF cycle
The family variant plus nearby markers, usually from both parents' samples too
Supported
Setup takes weeks and the test finds only the variant it was built for
PGT-SR
Pieces of chromosomes swapped or flipped
A parent with a known translocation or inversion
Established for that narrow purpose
Chromosome structure for each embryo tested
Supported
Answers one question and no other
PGT-A
Missing or extra whole chromosomes
Older patients, and couples after repeated miscarriage or failed transfers
Contested. A 2021 New England Journal of Medicine trial of 1,212 women aged 20 to 37 in China found no gain in cumulative live births
Chromosome counts from low-depth sequencing
Permitted, after the mosaic question is asked
A mosaic or borderline result can mark an embryo abnormal that might have developed normally
PGT-P
Polygenic risk scores for common diseases; some vendors also offer height or intelligence
Parents with several healthy embryos who want them ranked
ACMG (2024): insufficient evidence of clinical utility, should not be offered clinically. ESHG (2021): "unproven, unethical"
In whole-genome versions, a sequenced genome of a person who has not been born
Members asked not to use it
Orchid launched its whole-genome embryo report at $2,500 per embryo in December 2023, and it creates the most complete file of any option
01
IF YOUR FAMILY ALREADY HAS A NAME FOR IT, PGT-M IS THE TEST
The letter the Rite of Tidings asked you to write, with the gene and the exact variant, is the same piece of paper a PGT-M lab needs. With it the lab designs a test for that one change in your family, often using cheek swabs or blood from both parents and sometimes from the relative who tested first, and checks that it works before any embryo is biopsied. Plan for weeks. For Huntington's disease there is a version called exclusion testing, which lets a parent at risk avoid passing on the gene without ever learning whether they carry it themselves. The Church holds that this is one of the kindest things genetics has produced.
02
ASK WHAT "ABNORMAL" MEANT BEFORE ANYTHING IS DISCARDED
PGT-A is sold to many IVF patients as routine. The evidence is thinner than the brochure. In the 2021 trial published in the New England Journal of Medicine, women with several good embryos who skipped PGT-A did no worse at taking a baby home, and the American Society for Reproductive Medicine has said the data do not support offering it to every patient. Part of the problem is biological. The biopsy takes a few cells from the layer that will become the placenta, and an embryo can carry a mix of normal and abnormal cells, so the sample can disagree with the embryo. Some embryos reported as mosaic have been transferred and become healthy children. Before your clinic discards one, ask in writing whether the result was abnormal or mosaic, and what threshold the lab used.
03
A POLYGENIC SCORE IS A FORECAST NOBODY CAN CHECK FOR FIFTY YEARS
In May 2020 a girl named Aurea was born in the United States after her parents used Genomic Prediction to choose, from four embryos, the one scored least likely to develop heart disease, diabetes and cancer. In 2025 two newer companies, Herasight and Nucleus Genomics, began advertising scores for intelligence. The professional bodies have not moved with them. The American College of Medical Genetics and Genomics said in 2024 that the evidence does not support offering PGT-P as a clinical service, and the European Society of Human Genetics had already called it unproven and unethical. The arithmetic is unkind to the sales pitch. Embryos from the same two parents differ from each other far less than strangers do, and most scores were built from people of European ancestry, so they predict worse for everyone else. The Church asks members not to rank their embryos this way, and would ask it even if the scores were twice as good. A child should not arrive already graded.
04
THE SILENT PARTY
Every form in the clinic was signed by someone who will not have to live inside the genome it describes.
05
THE FILE OUTLIVES THE CHOICE
A clinic guide ends at transfer day. This rite starts there. A whole-genome embryo report is the complete DNA sequence of a future person, made before birth and held by a company that person will never have heard of. The same is true, in smaller ways, of every PGT result, and of the embryos you did not transfer. Before the biopsy, ask the lab four things in writing: how long it keeps the sequence data, whether any of it can be used for research or to train software, what happens to it if the company is sold or fails, and how a parent requests deletion. The last question is not hypothetical. 23andMe filed for Chapter 11 in March 2025, as the Rite of Sanctuary records, and its customers' DNA was among the assets. Any use for model training falls under the Machine Covenant. Deletion follows the steps of the Rite of Severance.
06
HAND THE FILE TO THE CHILD AT EIGHTEEN
The Nativity Rite holds a newborn's genome in trust until the child can consent. An embryo's genome deserves the same, with more care, because it was read sooner. Keep the PGT-M result; it is medical history and the child will need it. Ask the lab to delete any polygenic scores once a pregnancy is established. Then write the child a plain note saying which tests were run and why, and leave it with the instructions the Last Rites of the Genome asked you to keep.
WHERE EACH TEST FITS (AND WHERE IT DOES NOT)
PGT-M
FITS: A known family variant for a serious condition, including Huntington's through exclusion testing.
DOES NOT: Fishing for conditions nobody in the family is known to carry.
PGT-SR
FITS: A parent with a known chromosome rearrangement.
DOES NOT: Anyone without one.
PGT-A
FITS: Couples who have weighed the mosaic question and still want a count, especially after repeated losses. The 2021 trial studied women 37 and younger with several good embryos, which is not everyone, and the Church concedes that an older patient may reasonably read the evidence differently.
DOES NOT: As an unexplained default line on an IVF invoice.
PGT-P
FITS: Its supporters make their strongest case for parents with several chromosomally normal embryos and heavy family history of a common disease such as type 1 diabetes. That case is not foolish.
DOES NOT: Anywhere the Church has a say. The no rests on consent as much as on the numbers, and we would rather say so than pretend the statistics settle it.
"CHOOSE AGAINST A DISEASE. NEVER FOR A RANK."
Before the biopsy, write one sentence naming the test you chose and the reason. Staple the lab's answers to the four questions from the fifth station beneath it. If a lab will not answer them, choose another lab; there are many. Keep the page with the child's papers, and use the Consent Withdrawal Form in the Covenant if you later want the data destroyed. Parents who want to raise a child under this doctrine, and to stand with others doing the same, can join the congregation; membership does not require surrendering any genetic material, yours or the embryo's.
The Rite of Selection is the Church's doctrine of the screened embryo: which preimplantation genetic tests a member may use during IVF, and what happens to the genome data they create. The Church supports PGT-M for a known family variant behind a serious condition, accepts PGT-A and PGT-SR as ordinary IVF medicine with real limits, and asks members not to use polygenic embryo scores (PGT-P), which the American College of Medical Genetics and Genomics said in 2024 should not be offered clinically. It is presented as doctrine and practice, not legal or medical advice.
How the doctrine becomes a practical question
The rite becomes practical before the biopsy. A member names the test and the reason in one sentence, asks before any embryo is discarded whether a PGT-A result was abnormal or mosaic, and gets the lab's answers in writing on how long it keeps sequence data, whether the data can be used for research or to train software, what happens if the company is sold, and how deletion works. Polygenic scores are deleted once a pregnancy is established, the PGT-M result is kept as medical history, and the child is told at eighteen which tests were run.
What independent records establish
The ethical concern has verifiable public anchors. UNESCO adopted its Universal Declaration on the Human Genome and Human Rights in 1997. Article 5 says that, for research, treatment, or diagnosis affecting a genome, “the prior, free and informed consent of the person concerned shall be obtained.” Articles 6 and 7 separately address genetic discrimination and confidentiality. These are external principles; GeneSovereign’s claim that the genome is sacred remains doctrine and needs no invented scientific citation.
In the United States, Public Law 110-233—the Genetic Information Nondiscrimination Act of 2008—was enacted on May 21, 2008. Its two principal titles address health-insurance and employment discrimination. The statute defines a genetic test as analysis of human DNA, RNA, chromosomes, proteins, or metabolites that detects specified genetic changes. Those protections are real but bounded; this page does not present them as a universal genetic-privacy law.
A 2023 Federal Trade Commission genetic-privacy case provides a concrete custody warning. The FTC alleged that 1Health.io left nearly 2,400 health reports and raw genetic data from at least 227 consumers in publicly accessible cloud-storage buckets. The proposed order required third-party laboratories to destroy consumer DNA samples retained for more than 180 days. These figures describe that enforcement record, not GeneSovereign users or services.
Sources, scope, and collective authorship
UNESCO: Universal Declaration on the Human Genome and Human Rights (adopted 11 November 1997; endorsed by UN General Assembly resolution 53/152) — primary ethics instrument and quoted source. Published at unesco.org/en/legal-affairs/universal-declaration-human-genome-and-human-rights.
This page is authored by the Church of GeneSovereign as an anonymous collective, also called the Council. The site has no named individual spokesperson or external professional profile, so none is implied. Machine-readable reason: collective_org_internal_identity_no_external_profile. Legal and regulatory statements above are limited to what the linked primary sources establish; devotional claims remain explicitly matters of belief.
